Elon Musk’s Neuralink company has said it has implanted its wireless brain implant device into a human being for the first time, following FDA approval of clinical trials
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.<